Armata Pharmaceuticals (ARMP) Share-based Compensation (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 70.09% |
| Dec 31, 2025 | 1.61% |
| Sep 30, 2025 | 8.17% |
| Jun 30, 2025 | -26.38% |
| Mar 31, 2025 | 120.62% |
| Dec 31, 2024 | -47.16% |
| Sep 30, 2024 | -49.81% |
| Jun 30, 2024 | 150.00% |
| Mar 31, 2024 | 176.68% |
| Dec 31, 2023 | 151.74% |
| Sep 30, 2023 | -242.91% |
| Jun 30, 2023 | -69.54% |
| Mar 31, 2023 | 4.90% |
| Dec 31, 2022 | -3.43% |
| Sep 30, 2022 | -10.85% |
| Jun 30, 2022 | 92.49% |
| Mar 31, 2022 | -25.75% |
| Dec 31, 2021 | 41.58% |
| Sep 30, 2021 | -48.29% |
| Jun 30, 2021 | 7.72% |
| Mar 31, 2021 | -2.32% |
| Dec 31, 2020 | 30.02% |
| Sep 30, 2020 | -26.82% |
| Jun 30, 2020 | -13.22% |
| Mar 31, 2020 | -0.19% |
| Dec 31, 2019 | -58.13% |
| Sep 30, 2019 | 245.03% |
| Jun 30, 2019 | 631.31% |
| Mar 31, 2019 | 10,000.00% |
| Dec 31, 2018 | -112.50% |
| Sep 30, 2018 | -38.46% |
| Jun 30, 2018 | -89.34% |
| Mar 31, 2018 | -7.58% |
| Dec 31, 2017 | 34.69% |
| Sep 30, 2017 | -67.22% |
| Jun 30, 2017 | 74.85% |
| Mar 31, 2017 | -42.42% |
| Dec 31, 2016 | -11.08% |
| Sep 30, 2016 | -39.05% |
| Jun 30, 2016 | -32.84% |